Attributes | Values |
---|
rdf:type
| |
rdfs:seeAlso
| |
Description
| - Certain 6,9-disubstituted purine derivatives and their pharmaceutically acceptable salts of the general formula ##STR00001## are provided wherein R6 and R9 are as defined in the specification. These 6,9-disubstituted purine derivatives and their pharmaceutically acceptable salts are useful in compositions for treating mammalian cells, and especially human skin cells, in order to ameliorate the adverse effects of aging, treat skin disease states, treat immunological responses resulting from or associated with inflammation, and the like.
- Certain 6,9-disubstituted purine derivatives and their pharmaceutically acceptable salts of the general formula ##STR00001## are provided wherein R6 and R9 are as defined in the specification. These 6,9-disubstituted purine derivatives and their pharmaceutically acceptable salts are useful in compositions for treating mammalian cells, and especially human skin cells, in order to ameliorate the adverse effects of aging, treat skin disease states, treat immunological responses resulting from or associated with inflammation, and the like. (en)
|
Title
| - 6, 9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions
- 6, 9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions (en)
|
skos:prefLabel
| - 6, 9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions
- 6, 9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions (en)
|
skos:notation
| - RIV/61389030:_____/13:00425881!RIV14-AV0-61389030
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...cisloPatentuVzoru
| |
http://linked.open...eleniPatentuVzoru
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/61389030:_____/13:00425881
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - purine derivatives; treating mammalian cells; immunological responses (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...ontrolniKodProRIV
| |
http://linked.open.../licencniPoplatek
| |
http://linked.open...ydaniPatentuVzoru
| |
http://linked.open...atelePatentuVzoru
| - United States Patent and Trademark Office (USPTO)
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...ydaniPatentuVzoru
| |
http://linked.open...iv/tvurceVysledku
| - Doležal, Karel
- Strnad, Miroslav
- Spíchal, Lukáš
- Voller, Jiří
- Zatloukal, Marek
- Szüčová, Lucie
- Massino, F. J.
|
http://linked.open...mniOchranaPatentu
| |
http://linked.open...avai/riv/vlastnik
| |
http://linked.open...itiJinymSubjektem
| |
http://linked.open...uzitiPatentuVzoru
| |
http://linked.open...n/vavai/riv/zamer
| |
http://linked.open...stnikPatentuVzoru
| - Ústav experimentální botaniky AV ČR, v. v. i
|